Determinants of drug delivery and transport to solid tumors.
about
Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidCurrent advances in mathematical modeling of anti-cancer drug penetration into tumor tissuesIn silico modelling of treatment-induced tumour cell kill: developments and advancesBioavailability and efficacy of a gap junction enhancer (PQ7) in a mouse mammary tumor model3D Cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayerPredicting in vivo glioma growth with the reaction diffusion equation constrained by quantitative magnetic resonance imaging data.Delivery of siRNA therapeutics: barriers and carriers.Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib.Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.Non-condensing polymeric nanoparticles for targeted gene and siRNA deliveryTargeted drug delivery in cancer therapy.Drug delivery to tumours: recent strategies.Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.Integrating cell-cycle progression, drug penetration and energy metabolism to identify improved cancer therapeutic strategiesImproving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.Biodegradable intraprostatic doxorubicin implants.Polymeric micelles for neoadjuvant cancer therapy and tumor-primed optical imaging.Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamicsAn imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour modelsPolymeric drug delivery systems for localized cancer chemotherapy.Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors.Advances in image-guided intratumoral drug delivery techniques.Preclinical models in electrochemotherapy: the role of veterinary patients.Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: an approach to improve the therapeutic index of highly toxic chemotherapy drugs.Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.Acridine Orange/exosomes increase the delivery and the effectiveness of Acridine Orange in human melanoma cells: A new prototype for theranostics of tumors.A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules.Monitoring the dynamics of Src activity in response to anti-invasive dasatinib treatment at a subcellular level using dual intravital imagingDefinition of novel electrochemotherapy parameters and validation of their in vitro and in vivo effectiveness.Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems.Potential of amino acid/dipeptide monoester prodrugs of floxuridine in facilitating enhanced delivery of active drug to interior sites of tumors: a two-tier monolayer in vitro study.Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors.Mechanochemically activated doxorubicin nanoparticles in combination with 40 MHz frequency irradiation on A-549 lung carcinoma cells.Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumorsCellular uptake and concentrations of tamoxifen upon administration in poly(epsilon-caprolactone) nanoparticlesCharacterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems.Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations.Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour.
P2860
Q26799981-5855CA8A-A893-4145-9894-EF7EAB38FE12Q26827129-D2784051-C4A7-4800-B8AE-CDD2C2F3C205Q27011493-F6F1908F-8038-4791-92E5-201CA2B8582CQ28533863-40A53536-B88D-471D-BAF4-1366D40F6404Q28544801-0EB96EDB-D4C1-47BF-A2EB-EA866DF0052BQ30964764-74D85A03-0286-4B04-B0E8-2F9597E18E9BQ34293708-B80FEB26-4FF1-4742-A361-44F802AC8B83Q34294361-14B8D26A-E29B-4F86-A7D1-22D9CCCA27DDQ34676773-4EE736AF-1329-42FD-A888-68CC2D08AFCFQ35190149-E89C3056-CD67-4C75-B4A0-8EC65F7133B0Q36200150-7D6835A5-11CE-4B43-8E88-95C08E5AE030Q36301712-5CB2E11B-1245-4CBB-A141-FD8C0448DFC4Q36791673-CE521B02-FE40-42AE-99C5-4C618B3333B7Q36840074-C94438AA-93A8-4FC2-BF77-16B81CC2C5B4Q36848111-D18DDD71-180F-4955-8B5B-0AEB66836B81Q37361914-A756A100-897D-453B-BF8B-3379B286A218Q37427858-BC48413F-BA57-4607-9782-E94EDA2DF10FQ37435420-7D52CEF4-5326-4C7D-8CF6-2BB5270556B7Q37489267-5070F9D8-D63E-4EB7-A60F-3B6AA300B084Q37739481-6DE198CC-C51F-4BED-8C7A-7D32BA03B42FQ37908136-1A260056-3D94-416A-8951-1A269E18CA89Q38027851-2211D7C4-B9A3-4926-82E6-6019D5617C78Q38029365-ABADE0C5-CEDD-4EE5-B42B-4F7AA8F93CBDQ38590768-08C70099-83C8-4F00-92D0-8C61039386CFQ38685860-CC8032CD-4AE4-4C8C-A3DB-4A8A26002B4AQ38713579-2122994F-09E7-4382-ABC2-5765B9939373Q38754657-657FABC0-93B1-46CF-8BB6-D0524CDA9C5DQ38931516-31C34C49-F761-40A4-9BA3-5559D7528261Q39036284-09579DB6-2002-40BF-B59C-F7EE811141ECQ39371494-74D331EB-0B58-4ABA-BE31-B7F7423135B0Q39411175-BA5193B5-CA08-4678-9CEB-A2F20614C108Q39525005-D25AFE16-DA7B-4A1F-9FC2-1FE0D0B4222FQ40075182-69E5971D-A62D-4740-9E9F-5E2F3C971536Q40396401-349BCB25-B82F-42F2-9E9B-BDFDA2277F83Q41529677-E21D88D1-60E3-458D-879E-DC8F557418FEQ42129363-345FDC30-07CD-406A-B1BA-3A37DC75A794Q42152277-CF9B7F2D-58B2-49FF-9F6B-074A62C24F46Q42551562-728A4805-3E52-44B4-BA44-E60EB45EFA86Q42782242-8E13C4B1-DF69-4313-A4DE-862B7E0B94D6Q45204001-005BD6F9-FA5D-421D-8BC0-E07ABF8C535C
P2860
Determinants of drug delivery and transport to solid tumors.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Determinants of drug delivery and transport to solid tumors.
@ast
Determinants of drug delivery and transport to solid tumors.
@en
Determinants of drug delivery and transport to solid tumors.
@nl
type
label
Determinants of drug delivery and transport to solid tumors.
@ast
Determinants of drug delivery and transport to solid tumors.
@en
Determinants of drug delivery and transport to solid tumors.
@nl
prefLabel
Determinants of drug delivery and transport to solid tumors.
@ast
Determinants of drug delivery and transport to solid tumors.
@en
Determinants of drug delivery and transport to solid tumors.
@nl
P2093
P1476
Determinants of drug delivery and transport to solid tumors.
@en
P2093
Wientjes MG
P356
10.1016/S0168-3659(01)00308-X
P407
P577
2001-07-01T00:00:00Z